Japan ' s Ono Pharma to buy U.S. drugmaker Deciphera for $2.4bn

OSAKA -- Ono Pharmaceutical plans to purchase an American cancer drug maker for $2.4 billion in its largest acquisition yet, seeking growth with new-drug candidates as key patents on the Japanese company's Opdivo cancer immunotherapy expire from 2028. Ono announced Tuesday an agreement to acquire…#osaka #onopharmaceutical #opdivo #deciphera
Source: Reuters: Health - Category: Consumer Health News Source Type: news